1.      Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720–1748. doi:10.1038/s41375-022-01620-2.

2.      Ansell SM. Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98(5):798-821. doi:10.1002/ajh.26917

3.      Brugières L, Le Deley MC, Rosolen A, et al. Impact of methotrexate administration dose and schedule on outcome in childhood anaplastic large cell lymphoma: Results of the ALCL99 randomized trial. J Clin Oncol. 2009;27(6):897-903. doi:10.1200/JCO.2008.18.1483.

4.      Burkhardt B, Oschlies I, Klapper W, Zimmermann M, Woessmann W. Non-Hodgkin lymphoma in children and adolescents. Dtsch Arztebl Int. 2018;115(22):373-380. doi:10.3238/arztebl.2018.0373

5.      Campo E, Jaffe ES, Cook JR, et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140(11):1229-1253. doi:10.1182/blood.2022015851.

6.      Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059-3068. doi:10.1200/JCO.2013.54.8800.

7.      Children's Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. Version 6.0. Monrovia (CA): Children's Oncology Group; 2023.

8.      Crombie JL, LaCasce AS. The treatment of Burkitt lymphoma in adults. Blood. 2021;137(6):743-750. doi:10.1182/blood.2020006850.

9.      Eichenauer DA, Aleman BMP, André M, et al. Hodgkin lymphoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(9):1148-1160. doi:10.1016/j.annonc.2020.03.315

10.   Fan G, Wang Z, Hao M, Li J. Bispecific antibodies and their applications. Journal of Hematology & Oncology. 2015;8:130. doi:10.1186/s13045-015-0227-0.

11.  Gambacorti-Passerini C, Orlov S, Zhang L, et al. Long-term effects of crizotinib in ALK-positive tumors (including anaplastic large-cell lymphoma). J Natl Cancer Inst. 2020;112(3):253-262. doi:10.1093/jnci/djz058

12.  Goldman S, Smith L, Galardy P, et al. Rituximab with FAB/LMB 96 chemotherapy for high-risk childhood B-cell non-Hodgkin lymphoma: a Children's Oncology Group report. Pediatr Blood Cancer. 2013;60(11):1815-1820. doi:10.1002/pbc.24603

13.  Kelly KM, Cole PD, Pei Q, et al. Response-adapted therapy for the treatment of children with newly diagnosed high-risk Hodgkin lymphoma. J Clin Oncol. 2023;41(5):937-946. doi:10.1200/JCO.22.01380

14.  Locatelli F, Mauz-Körholz C, Neville K, et al. Brentuximab vedotin for paediatric relapsed or refractory Hodgkin lymphoma and systemic anaplastic large-cell lymphoma. Lancet Haematol. 2018;5(10):e450-e461. doi:10.1016/S2352-3026(18)30126-0.

15.  Mauz-Körholz C, Metzger ML, Kelly KM, et al. Pediatric Hodgkin lymphoma. J Clin Oncol. 2015;33(27):2975-2985. doi:10.1200/JCO.2014.59.4853.

16.  Minard-Colin V, Brugières L, Reiter A, et al. Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead. J Clin Oncol. 2015;33(27):2963–2974. doi:10.1200/JCO.2014.59.5827.

17.  Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 1994;263(5151):1281-1284. doi:10.1126/science.8122112.

18.  Mossé YP, Lim MS, Voss SD, et al. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. Lancet Oncol. 2013;14(6):472-480. doi:10.1016/S1470-2045(13)70095-0.

19.  Naresh KN, Ibrahim HAA, Lazzi S, et al. Diagnosis of Burkitt lymphoma using an algorithmic approach—current status and future directions. Br J Haematol. 2011;154(1):3-16. doi:10.1111/j.1365-2141.2011.08712.x

20.  Oschlies I, Burkhardt B, Salaverria I, Rosenwald A. Pediatric follicular lymphoma and pediatric nodal marginal zone lymphoma: recent biologic insights. Hematology Am Soc Hematol Educ Program. 2019;2019(1):476-482. doi:10.1182/hematology.2019000057.

21.   Passoni L, Mussolin L, Brugieres L. Targeting ALK in pediatric anaplastic large cell lymphoma. Cancers (Basel). 2023;15(3):737. doi:10.3390/cancers15030737.

22.  Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. 8th ed. Philadelphia: Wolters Kluwer; 2021. (Pediatric Non-Hodgkin Lymphoma bölümü.)

23.  Pui CH, Nichols KE, Yang JJ. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia. Nat Rev Clin Oncol. 2019;16(4):227-240. doi:10.1038/s41571-018-0136-6.

24.  Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, et al. Childhood cancer predisposition syndromes—A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A. 2017;173(4):1017-1037. doi:10.1002/ajmg.a.38142

25.  Rosolen A, Perkins SL, Pinkerton CR, et al. Revised International Pediatric Non-Hodgkin Lymphoma Staging System. J Clin Oncol. 2015;33(18):2112-2118. doi:10.1200/JCO.2014.59.7203.

26.  Sandlund JT. Non-Hodgkin lymphoma in children. Curr Hematol Malig Rep. 2015;10(3):237-243. doi:10.1007/s11899-015-0266-6

27.  Schuster SJ, Bishop MR, Tam CS, et al. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N Engl J Med. 2019;380(1):45-56. doi:10.1056/NEJMoa1804980.

28.  Schuster SJ, Svoboda J, Chong EA, et al. Chimeric antigen receptor T cells in refractory B-cell lymphomas. N Engl J Med. 2017;377(26):2545-2554. doi:10.1056/NEJMoa1708566.

29.  Shanbhag S, Ambinder RF. Hodgkin lymphoma: A review and update on recent progress. CA Cancer J Clin. 2018;68(2):116-132. doi:10.3322/caac.21438.

30.  Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103. doi:10.3322/caac.21219. 2.

31.  Winter SS, Dunsmore KP, Devidas M, et al. Improved survival for children and young adults with T-cell acute lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: Results from the Children's Oncology Group AALL0434 study. J Clin Oncol. 2018;36(29):2926-2934. doi:10.1200/JCO.2018.78.0946.

32.  Woessmann W. How I treat children and adolescents with mature B-cell lymphoma. Br J Haematol. 2022;196(6):1293-1303. doi:10.1111/bjh.17945

33.  Young LS, Yap LF, Murray PG. Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer. 2016;16(12):789-802. doi:10.1038/nrc.2016.92.